Inhibition of JNK signaling by small molecule inhibitor has been attracted attention for therapeutic target to treat several diseases, such as cancer, obesity, and inflammation [28,29,30]. Here, MAPK8 is linked to obesity due to melanocortin 4 receptor deficiency.